Treatment of arterial thrombosis with low molecular weight heparins.
Chesebro
J H
JH
Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029-6574, USA.
D000925:Anticoagulants / Q000627:therapeutic use*; D001158:Arteries; D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013917:Thrombin / Q000502:physiology; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D013917:Thrombin